Works matching DE "PROGRAMMED cell death 1 receptors"

Results: 5000

PD-1 induces autophagy via the PI3K/AKT/FoxO1 pathway to promote infectious bursal disease virus replication.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1585012

By:

Zhang, Qiuyu;
Yue, Feng;
Sun, Guopeng;
Jiang, Liwei;
Li, Peng;
Zhu, Yanping;
Liu, Zhike;
Zhu, Yangzhao;
Niu, Ruiyan;
He, Hua;
Sun, Zilong;
Wang, Xuannian

Publication type:

Article

Unveiling the power of plumbagin: revitalizing exhausted T cells to combat tongue cancer.

Published in:

Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03892-x

By:

Zhang, Rongrong;
Jiang, Qingkun;
Guo, Runying;
Guo, Ke;
Qiu, Jiaxuan

Publication type:

Article

Immune checkpoint inhibitor-associated diabetes mellitus: the case series report.

Published in:

Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1589630

By:

Ma, Yuhong;
Xue, Jing;
Cheng, Qianwen;
Qian, Hesheng;
Du, Yingying

Publication type:

Article

Integrative habitat analysis and multi-instance deep learning for predictive model of PD-1/PD-L1 immunotherapy efficacy in NSCLC patients: a dual-center retrospective study.

Published in:

BMC Medical Imaging, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12880-025-01828-5

By:

Huang, Xiaoxiao;
Huang, Xiaoxin;
Xie, Yurun;
Wang, Kui;
Bai, Housheng;
Ning, Ruiling;
Zhu, Xiqi;
Huang, Deyou;
Jin, Guanqiao

Publication type:

Article

The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-61780-4

By:

Saddawi-Konefka, Robert;
Msari, Riyam Al;
Tang, Shiqi;
Philips, Chad;
Sadat, Sayed;
Clubb, Lauren M.;
Luna, Sarah;
Fassardi, Santiago;
Jones, Riley;
Pietryga, Ida Franiak;
Faraji, Farhoud;
Schokrpur, Shiruyeh;
Yung, Bryan S.;
Allevato, Michael M.;
Decker, Kelsey E.;
Nasamran, Chanond A.;
Chilin-Fuentes, Daisy;
Rosenthal, Sara Brin;
Jensen, Shawn M.;
Fox, Bernard A.

Publication type:

Article

CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1629879

By:

Wang, Jia-Wen;
Feng, Ying-Fa;
Liu, Jia-Hui

Publication type:

Article

Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling.

Published in:

BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-05020-8

By:

Li, Bin-bin;
Jiang, Yi-yang;
Li, Xue;
Yu, Min-min;
Meng, Qian;
Wang, Dan-ni;
Zang, Ji-miao;
Xu, Fei

Publication type:

Article

RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression.

Published in:

Journal of Cancer, 2025, v. 16, n. 10, p. 3080, doi. 10.7150/jca.111459

By:

Xia Gao;
Xiuqin Zhang;
Junjie Huang;
Zhenyu Tan;
Jing Yang;
Liuhong Yuan;
Pengjun Wang;
Feier Chen;
Huiyan Wu;
Changyi Feng;
Hong Yu;
Shisan Bao;
Da Fu;
Kun Tao

Publication type:

Article

靶向叶酸受体α（FRα）的程序性细胞死亡受体1敲低型嵌合抗原受体T细胞杀伤肝癌细胞的效果分析

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2025, v. 41, n. 6, p. 1128, doi. 10.12449/JCH250619

By:

温, 军业;
张, 浚琪;
任, 行;
张, 海强;
叶, 学帅

Publication type:

Article

Fenotipo de inestabilidad de microsatélites en Carcinoma colorrectal mediante la expresión de proteínas reparadoras del ADN.

Published in:

Ciencia, Tecnología y Salud, 2024, v. 11, n. 2, p. 83, doi. 10.36829/63CTS.v11i2.1650

By:

Rodas-Pernillo, Orlando;
Oregón, Edith;
Cóbar, Oscar;
Chakhtoura, Abbas;
Cardona, J. Hugo;
Nave, Federico;
Hernández, Elisa

Publication type:

Article

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Published in:

Clinical Medicine Insights: Oncology, 2025, p. 1, doi. 10.1177/11795549251350188

By:

Ding, Xiaojie;
Chen, Di;
Zhang, Zhenyu;
Qi, Ying;
Chen, Dikang;
Wen, Jianbo;
Wang, Yuyuan;
Cheng, Haixia;
Ji, Chunxia;
Chen, Lingchao;
Tang, Chao;
Yao, Yu

Publication type:

Article

Risk factors and outcomes of thyroid immune-related adverse events following PD-1/PD-L1 inhibitors treatment in a large tertiary Chinese center.

Published in:

BMC Endocrine Disorders, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12902-025-01986-1

By:

Gong, Wenwen;
Zheng, Erhan;
Liu, Minchao;
Han, Yaliang;
Lyu, Zhaohui;
Guo, Qinghua

Publication type:

Article

Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2265, doi. 10.3390/cancers17132265

By:

Muto, Yusuke;
Fujimura, Taku;
Asano, Yoshihide

Publication type:

Article

Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2199, doi. 10.3390/cancers17132199

By:

Khalil, Maryam;
Tsao, Ming-Sound

Publication type:

Article

Immune Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2125, doi. 10.3390/cancers17132125

By:

Gilson, Alice;
Tan, Vincent;
Koessler, Thibaud;
Meyer, Jeremy;
Meurette, Guillaume;
Liot, Émilie;
Ris, Frédéric;
Delaune, Vaihere

Publication type:

Article

Subclassification-Specific Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Implications for Appropriate Pharmacotherapy.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2082, doi. 10.3390/cancers17132082

By:

Kinoshita, Masahiko;
Sato, Yasunori;
Kubo, Shoji;
Shinkawa, Hiroji;
Kimura, Kenjiro;
Nishio, Kohei;
Tanaka, Ryota;
Kurihara, Shigeaki;
Ishizawa, Takeaki

Publication type:

Article

Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review.

Published in:

Molecules, 2025, v. 30, n. 13, p. 2686, doi. 10.3390/molecules30132686

By:

Kciuk, Mateusz;
Wanke, Katarzyna;
Kruczkowska, Weronika;
Marciniak, Beata;
Kontek, Renata

Publication type:

Article

BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6205, doi. 10.3390/ijms26136205

By:

Liao, Zhangjun;
Wu, Shuyi;
Shi, Zhenyi;
Chen, Donghui;
Chen, Jinrui;
Zhang, Hua

Publication type:

Article

Membrane-spanning 4 domains subfamily A member 4A inhibition promotes M1 macrophage polarization and enhances anti-gastric cancer immune response.

Published in:

CytoJournal, 2025, v. 22, p. 1, doi. 10.25259/Cytojournal_271_2024

By:

Zhang, Xinyue;
Na, Di

Publication type:

Article

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03934-8

By:

Zhang, Jianfei;
Liu, Min;
Li, Dongyang;
Luo, Jiali;
Wang, Min

Publication type:

Article

The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer.

Published in:

Oncology, 2025, v. 103, n. 7, p. 610, doi. 10.1159/000542188

By:

Guo, Wei;
Zhao, Shuo;
Yan, Keqiang;
Fan, Yidong;
Liu, Jikai

Publication type:

Article

Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study.

Published in:

Endocrinology & Metabolism, 2025, v. 40, n. 3, p. 459, doi. 10.3803/EnM.2024.2180

By:

Shintaro Iwama;
Tomoko Kobayashi;
Tetsushi Izuchi;
Koji Suzuki;
Takanori Murase;
Masahiko Ando;
Tomoko Handa;
Takeshi Onoue;
Takashi Miyata;
Mariko Sugiyama;
Daisuke Hagiwara;
Hidetaka Suga;
Ryoichi Banno;
Tetsunari Hase;
Shoichiro Mori;
Tomoyasu Sano;
Shusuke Akamatsu;
Masashi Akiyama;
Makoto Ishii;
Hiroshi Arima

Publication type:

Article

Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14562-6

By:

Bai, Junjie;
Huang, Jianjia;
Ye, Yushi;
Lin, Jun;
Wen, Yahui;
Cai, Zicheng;
Chen, Peihuang;
Shangguan, Tong;
Zou, Gaoyu;
Qiu, Qianyi;
Chen, Ru;
Liu, Rong;
Cai, Weizhong;
Zhu, Shaoxing;
Chen, Jianhui;
Li, Xiaoyan

Publication type:

Article

Correction to: Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer.

Published in:

2025

By:

Zhao, Jiaqi;
Liu, Maolin;
Zhu, Chongmei;
Li, Zhuolin;
Liu, Zuhui;
Abulizi, Dilimulati;
Liu, Siqing;
Wang, Xin;
Yang, Haoxian;
Hou, Xue

Publication type:

Correction Notice

Programmed Death Ligand 1 Modulation by Bacillus Calmette-Guérin and Toll-Like Receptor Agonists in Distinct Breast Cancer Cell Subtypes.

Published in:

International Journal of General Medicine, 2025, v. 18, p. 3401, doi. 10.2147/IJGM.S531858

By:

Barbosa, Gabriela;
Godoy, Maria Carolina Ximenes De;
Bighetto, Caroline Cavalli;
Skakum, Emily Macedo;
Pascoal, Lívia Bitencourt;
Gambero, Alessandra;
Reis, Leonardo O

Publication type:

Article

Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2025, v. 33, n. 2, p. 1, doi. 10.1007/s40199-025-00564-z

By:

Rezaei, Ramazan;
Khani, Hedieh Haji Khodaverdi

Publication type:

Article

PD-L1 Expression and Tumor Microenvironment Dynamics in Diffuse Large B-Cell Lymphoma: Immunophenotypic Insights.

Published in:

Journal of Medicine & Life, 2025, v. 18, n. 5, p. 463, doi. 10.25122/jml-2025-0078

By:

Halcu, Georgian;
Mureșan, Filip Cristian;
Niculae, Andrei;
Evsei-Seceleanu, Anca;
Lapadat, Mihai-Emilian;
Cerbu, Mihai Adrian;
Ceausu, Mihail

Publication type:

Article

Total neoadjuvant immunochemotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1611386

By:

Li, Xing;
Tang, Ligong;
Cheng, Fangyuan;
Xu, Yongchao

Publication type:

Article

Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous ß-catenin and cytoplasmic ß-catenin expression with the outcome of patients with clear cell renal cell carcinoma.

Published in:

Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2025, v. 169, n. 2, p. 107, doi. 10.5507/bp.2024.005

By:

Rozsypalova, Aneta;
Rosova, Blanka;
Filipova, Alzbeta;
Nikolov, Dimitar Hadzi;
Chloupkova, Renata;
Richter, Igor;
Zachoval, Roman;
Matej, Radoslav;
Melichar, Bohuslav;
Buchler, Tomas;
Dvorak, Josef

Publication type:

Article

Skin Reactions as a Prognostic Factor in Immunotherapy of Non-Small Cell Lung Cancer.

Published in:

International Medical Journal, 2025, v. 32, n. 2, p. 97

By:

Kolasa, Eliza;
Paluch, Alicja;
Koźlicka, Aleksandra;
Szklener, Katarzyna

Publication type:

Article

Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1612547

By:

Lin, Shihua;
Hong, Min;
Zhang, Jing;
Zhao, Wenting;
Li, Ke;
Wu, Chun;
Yang, Qiuyun;
Xiao, Yi;
Huang, Lanqing;
Wang, Jing;
Jia, Aijuan;
Wang, Xujia;
Yao, Sheng

Publication type:

Article

The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00983-w

By:

Daher-Ghanem, Narmeen;
Sharon, Shay;
Tao, Derrick;
Sun, Zhaoyu;
Rosales, Wesley;
Rajamanickam, Venkatesh;
Meng, Ryan;
Kaur, Lakhvir;
Bernard, Brady;
Piening, Brian;
Couey, Marcus;
Gough, Michael J.;
Kravchenko-Balasha, Nataly

Publication type:

Article

Exploring new avenues in non--muscle-invasive bladder cancer treatment.

Published in:: 2025
Publication type:: Conference Paper/Materials

Structure–activity relationship of <sup>18</sup>F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance.

Published in:

EJNMMI Radiopharmacy & Chemistry, 2025, v. 10, n. 1, p. 1, doi. 10.1186/s41181-025-00359-2

By:

Krutzek, Fabian;
Donat, Cornelius K.;
Stadlbauer, Sven

Publication type:

Article

Evaluation of polymorphism in BCL-2, PD-1, and PD-L1 genes in myelodysplastic neoplasms.

Published in:

Acta Haematologica Polonica, 2025, v. 56, n. 3, p. 222, doi. 10.5603/ahp.104373

By:

Kuszczak, Bartłomiej;
Łacina, Piotr;
Dratwa-Kuzmin, Marta;
Bogunia-Kubik, Katarzyna;
Wróbel, Tomasz;
Rybka, Justyna

Publication type:

Article

Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease.

Published in:

Scandinavian Journal of Gastroenterology, 2025, v. 60, n. 7, p. 698, doi. 10.1080/00365521.2025.2505622

By:

Nielsen, Morten Aagaard;
Bendix, Mia;
Hvas, Christian Lodberg;
Deleuran, Bent;
Reinert, Line S.;
Agnholt, Jørgen;
Dige, Anders

Publication type:

Article

Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14482-5

By:

Ansab, Muhammad;
Razi, Sepideh;
Nisa, Farwa;
Araib, Eiman;
Rath, Shree;
Khan, Iqra;
Ramzan, Noor Ul Huda;
Dilawar, Esha;
Saeed, Anwaar

Publication type:

Article

Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14459-4

By:

Lin, Lihui;
Lin, Yansong;
Chen, Wei;
Yang, Xia;
Guo, Xianwen;
Wu, Yanqin;
Yin, Xiaoyu;
Ding, Zhen;
Yun, Jingping

Publication type:

Article

Deciphering cardiotoxicity in PD-1/PD-L1 inhibitor treatment.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 2, doi. 10.5114/ceji.2025.151335

By:

Tabarkiewicz, Jacek;
Głodkowska-Mrówka, Eliza;
Eljaszewicz, Andrzej

Publication type:

Article

PD-1/PD-L1 inhibitor treatment associated with cardiotoxicity regulated by macrophage polarization and SOCS3/JAK/STAT3 signaling pathway.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 24, doi. 10.5114/ceji.2025.149377

By:

Fu, Jiding;
Wang, Ge;
Zeng, Lisi;
Lin, Jie;
Wei, Yier;
Xu, Wei;
Xu, Rui;
Xian, Lewu

Publication type:

Article

5‐ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD‐1 and CD103 in the Intermediate and Marginal Layers.

Published in:

European Journal of Immunology, 2025, v. 55, n. 6, p. 1, doi. 10.1002/eji.202451681

By:

Vanni, Anna;
Matani, Francesca;
Bonaudo, Camilla;
Mazzoni, Alessio;
Capone, Manuela;
Lamacchia, Giulia;
Salvati, Lorenzo;
Bartoli, Lucia;
Francalanci, Stefania;
Petti, Mirko;
Capelli, Federico;
Nozzoli, Filippo;
Cosmi, Lorenzo;
Liotta, Francesco;
Della Puppa, Alessandro;
Maggi, Laura;
Annunziato, Francesco

Publication type:

Article

Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directions.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1602529

By:

Vatsavai, Neeharika;
Kaur Bhinder, Sumeet;
Shaik, Rahaman;
Mahira, Shaheen;
Kapoor, Shruti;
Ali, Md Shadab;
Verma, Deepak;
Singh, Jay;
Badavenkatappa Gari, Sreelakshmi;
Upadhyay, Prabhat;
Meshkovska, Yeva;
Godugu, Chandraiah;
Thatikonda, Sowjanya;
Pooladanda, Venkatesh

Publication type:

Article

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1561942

By:

Tao, Chao;
Liu, Bingyao;
Dai, Yan;
Lv, Jinyi;
He, Huanhuan;
Ding, Qian;
Chen, Kun;
Wang, Ke;
Yang, Liuxuan;
Ren, Xiaoqun;
Zhou, Meiling

Publication type:

Article

A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products.

Published in:

Marine Drugs, 2025, v. 23, n. 6, p. 247, doi. 10.3390/md23060247

By:

Rabelo, Henrique;
Tsimiante, Ayana;
Binev, Yuri;
Pereira, Florbela

Publication type:

Article

Immune-Checkpoint Expression in Breast Cancer Patients: Clinicopathological Implications: A Retrospective Case Series Study.

Published in:

2025

By:

Quiroz-Bolaños, Angel;
Quintero-Ramos, Antonio;
Godínez-Rubí, Juliana Marisol;
Franco-Topete, Ramon;
González, Porfirio Gutiérrez;
Gutiérrez-Zepeda, Bricia M.;
Becerra-Loaiza, Denisse S.;
Topete, Antonio;
de Loera-Rodriguez, Cesar;
Toro-Arreola, Alicia Del;
Daneri-Navarro, Adrián

Publication type:

Case Study

The role of tumor-associated macrophages and PD-1/PD-L1 networking in colorectal cancer.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2025, v. 29, n. 2, p. 123, doi. 10.5114/wo.2025.150448

By:

Yerolatsite, Melina;
Torounidou, Nanteznta;
Amylidi, Anna-Lea;
Zarkavelis, George;
Hadjigeorgiou, Loizos;
Lampri, Evangeli;
Bali, Christina;
Georvasili, Vaia;
Kampletsas, Eleftherios;
Mauri, Davide

Publication type:

Article

The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325349

By:

Kong, Dehua;
Gao, Chunyan;
Yu, Yang;
Yang, Lu;
Ma, Ji;
Tang, Shimin;
Mao, Ying;
Li, Yong;
Li, Na

Publication type:

Article

Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2025, v. 77, n. 7, p. 817, doi. 10.1002/art.43125

By:

Spiliopoulou, Athina;
Iakovliev, Andrii;
Plant, Darren;
Sutcliffe, Megan;
Sharma, Seema;
Cubuk, Cankut;
Lewis, Myles;
Pitzalis, Costantino;
Barton, Anne;
McKeigue, Paul M.

Publication type:

Article

Mini‐review: Immunology in ovarian cancer.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 9, p. 2245, doi. 10.1111/jog.15730

By:

Taki, Mana

Publication type:

Article

Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 3, p. 473, doi. 10.1007/s11060-020-03636-z

By:

Zhou, Wenjianlong;
Zhang, Chuanbao;
Zhang, Dainan;
Peng, Jiayi;
Ma, Shunchang;
Wang, Xi;
Guan, Xiudong;
Li, Peiliang;
Li, Deling;
Jia, Guijun;
Jia, Wang

Publication type:

Article